Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA1AK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,552
Award facts
- Contract value 100% obligated
- $28,552.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Zepbound 5 mg/0.5 ml pens with a contract value of $28,552.30 and an ultimate completion date of January 7, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used for weight management, reflecting the federal government's procurement of contemporary pharmaceutical therapies for military healthcare systems and other federal medical institutions.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products, medical supplies, specialty medications, vaccines, and related healthcare commodities to support military treatment facilities and federal healthcare programs globally. AmerisourceBergen's consistent performance of competitively awarded federal contracts demonstrates its capability to efficiently fulfill critical pharmaceutical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FA1AK?
SPE2DR26FA1AK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FA1AK worth?
The government has obligated $28,552 on SPE2DR26FA1AK.
Is contract SPE2DR26FA1AK an order under another contract?
Yes. SPE2DR26FA1AK is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA1AK competed?
The extent of competition for SPE2DR26FA1AK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award